Maxigen Biotech Inc.TWSE: 1783

Announcement of the election of two additional directors at the Company's 2022 Annual General Meeting

· Issued by Maxigen Biotech Inc.
Close
Today's Information

Provided by: MAXIGEN BIOTECH INC.
SEQ_NO 2 Date of announcement 2022/06/21 Time of announcement 20:16:07
Subject
 Announcement of the election of two additional
directors at the Company's 2022 Annual General Meeting
Date of events 2022/06/21 To which item it meets paragraph 6
Statement
1.Date of occurrence of the change:2022/06/21
2.Elected or changed position (Please enter institutional director,
institutional supervisor, independent director, natural-person director or
natural-person supervisor):Institutional director
3.Title and name of the previous position holder:N/A
4.Resume of the previous position holder:N/A
5.Title and name of the new position holder:Institutional director
(1)TCI CO., Ltd. institutional director representative:
Tsong-Jieh Chiou
(2)Formosa Biomedical Technology Corp.
institutional director representative: Shih-Ming Lai
6.Resume of the new position holder:
(1)TCI CO., Ltd. institutional director representative:
Tsong-Jieh Chiou/
TCI CO., Ltd. Customer Successful Manager
(2)Formosa Biomedical Technology Corp. institutional
director representative: Shih-Ming Lai/
Deputy Director of Medical Business Development Center,
Formosa Plastics Group General Administration Office
7.Circumstances of change (Please enter "resignation", "dismissal",
"term expired", "death" or "new appointment"):New appointment
8.Reason for the change:Election of two additional directors
according to the Company's operational needs
9.Number of shares held by the new position holder when elected:
(1)TCI CO., Ltd.:17,579,881 shares
(2)Formosa Biomedical Technology Corp.: 7,534,235 shares
10.Original term (from __________ to __________):
2021/07/12 to 2024/07/11
11.Effective date of the new appointment:2022/06/21
12.Turnover rate of directors of the same term:2/9
13.Turnover rate of independent directors of the same term:N/A
14.Turnover rate of supervisors of the same term:N/A
15.Change in one-third or more of directors (Please enter "Yes" or
"No"):No
16.Any other matters that need to be specified:None

Company analysis

Earlier from Maxigen Biotech

All Maxigen Biotech news releases